Geoffrey Beran Rose
2021
In 2021, Geoffrey Beran Rose earned a total compensation of $2M as Chief Commercial Officer at Pulmonx Corp, a 149% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $144,324 |
|---|---|
| Option Awards | $744,084 |
| Salary | $380,000 |
| Stock Awards | $763,840 |
| Other | $666 |
| Total | $2,032,914 |
Rose received $763.8K in stock awards, accounting for 38% of the total pay in 2021.
Rose also received $144.3K in non-equity incentive plan, $744.1K in option awards, $380K in salary and $666 in other compensation.
Rankings
In 2021, Geoffrey Beran Rose's compensation ranked 5,993rd out of 12,415 executives tracked by ExecPay. In other words, Rose earned more than 51.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,993 out of 12,415 | 52nd |
Division Manufacturing | 2,538 out of 5,508 | 54th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 315 out of 801 | 61st |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 190 out of 522 | 64th |
Industry Surgical and Medical Instruments and Apparatus | 124 out of 327 | 62nd |
Source: SEC filing on April 15, 2022.
Rose's colleagues
We found two more compensation records of executives who worked with Geoffrey Beran Rose at Pulmonx Corp in 2021.